The Blue Ridge Bankshares Inc (BRBS) share price is expected to decrease by 100% over the next year. This is based on calculating the average 12-month share price estimate provided by 0 stock analysts who have covered BRBS. Price targets range from $ at the low end to $ at the high end. The current analyst consensus for BRBS is a sell. Please note analyst price targets are not guaranteed and could be missed completely.
Blue Ridge Bankshares Inc has a total of 0 Wall St Analyst ratings. There are 0 buy ratings, 0 ratings, and 0 sell ratings. Since most analysts have a sell consensus rating, the expectation is that Blue Ridge Bankshares Inc will perform worse than the market. Investors shouldn't rely purely on analyst ratings; we encourage investors to also take a look at the fundamental and technical analysis in their due diligence.
These are the latest 20 analyst ratings of BRBS.
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
---|---|---|---|---|
Data Not Found! |
When did it IPO
2004
Staff Count
507
Country
United States
Sector/Industry
Financial Services/Banks - Regional
CEO
Mr. G. William Beale
Market Cap
$289.6M
In 2023, BRBS generated $121.6M in revenue, which was a decrease of -20.36% from the previous year. This can be seen as a signal that BRBS's business is declining, and its share price could be worth less in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Summary - Blue Ridge Bankshares reported improved metrics in deposit growth, reduced noninterest expenses, and fewer nonperforming assets. The bank plans to exit fintech operations by end of 2024.
Why It Matters - Blue Ridge Bankshares shows strong financial performance with improved metrics and a strategic exit from fintech operations, indicating potential for increased profitability and reduced risk.
Summary - Kaskela Law LLC is investigating Blue Ridge Bankshares, Inc. (NYSE: BRBS) following a securities fraud complaint filed for investors who bought shares between February 3 and October 31, 2023.
Why It Matters - The investigation into Blue Ridge Bankshares for alleged securities fraud may signal potential legal and financial risks, impacting share prices and investor confidence.
Summary - Blue Ridge Bankshares raised $161.6 million in a private placement to support its business transformation and meets new regulatory capital ratios. Financial results for Q2 2024 were also announced.
Why It Matters - The successful capital raise of $161.6 million positions Blue Ridge Bankshares for growth and regulatory compliance, enhancing its financial stability and potential for future returns.
Summary - A lawsuit is pending for investors in Blue Ridge Bankshares (NYSE: BRBS) who bought shares before March 2023. Affected investors can contact the Shareholders Foundation for options.
Why It Matters - Pending lawsuits can lead to financial instability and reputational damage for companies. This situation may affect Blue Ridge Bankshares' stock price and investor sentiment.
Summary - Blue Ridge Bankshares raised $150 million in a private placement post-quarter to support business transformation and enhance compliance. Regulatory remediation efforts are on track.
Why It Matters - The $150 million capital raise enhances liquidity for Blue Ridge Bankshares, supporting its transformation and compliance efforts, which can improve operational stability and investor confidence.
Summary - A lawsuit is pending for investors in Blue Ridge Bankshares, Inc. (NYSE: BRBS) who purchased shares before March 2023. Affected shareholders can contact the Shareholders Foundation for options.
Why It Matters - Pending lawsuits can lead to financial uncertainty and potential losses for shareholders, impacting stock performance and investor sentiment in Blue Ridge Bankshares, Inc.